Phreesia, Inc. (NYSE:PHR) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Phreesia, Inc. (NYSE:PHR) have been assigned a consensus rating of “Moderate Buy” from the twelve brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $29.33.

PHR has been the subject of a number of recent research reports. DA Davidson reiterated a “buy” rating and set a $32.00 price target on shares of Phreesia in a research note on Thursday, September 5th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research note on Tuesday, December 10th. Royal Bank of Canada reissued a “sector perform” rating and set a $23.00 price target on shares of Phreesia in a research note on Friday, September 27th. Truist Financial upped their price target on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, Robert W. Baird decreased their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a research note on Wednesday, December 11th.

Insider Transactions at Phreesia

In other Phreesia news, insider Yvonne Hui sold 2,791 shares of the firm’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the sale, the insider now owns 27,228 shares in the company, valued at $569,609.76. This trade represents a 9.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Allison C. Hoffman sold 1,212 shares of the firm’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total transaction of $25,488.36. Following the transaction, the general counsel now directly owns 119,791 shares of the company’s stock, valued at approximately $2,519,204.73. This represents a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 90,342 shares of company stock worth $2,041,225. 5.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Phreesia

Several large investors have recently added to or reduced their stakes in PHR. Bank of New York Mellon Corp grew its position in shares of Phreesia by 8.4% during the second quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock worth $4,546,000 after acquiring an additional 16,614 shares during the last quarter. Peregrine Capital Management LLC boosted its position in shares of Phreesia by 11.3% in the 2nd quarter. Peregrine Capital Management LLC now owns 354,607 shares of the company’s stock valued at $7,518,000 after purchasing an additional 36,047 shares during the period. nVerses Capital LLC lifted its position in shares of Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after acquiring an additional 1,300 shares in the last quarter. Rhumbline Advisers lifted its stake in Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after acquiring an additional 853 shares in the last quarter. Finally, Arcadia Investment Management Corp MI grew its position in Phreesia by 13.9% during the second quarter. Arcadia Investment Management Corp MI now owns 88,625 shares of the company’s stock valued at $1,879,000 after purchasing an additional 10,800 shares in the last quarter. 92.10% of the stock is currently owned by institutional investors.

Phreesia Stock Performance

Shares of PHR opened at $25.76 on Friday. The stock has a market capitalization of $1.50 billion, a PE ratio of -17.52 and a beta of 0.98. The stock has a 50-day simple moving average of $21.18 and a 200-day simple moving average of $22.12. Phreesia has a 1 year low of $17.07 and a 1 year high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter in the prior year, the business posted ($0.58) EPS. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. On average, analysts predict that Phreesia will post -1.16 earnings per share for the current fiscal year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.